Literature DB >> 35400003

The Impact of Metastatic Lymph Node Size on Long-term Outcomes for pStage III Colon Cancer.

Chikara Maeda1, Yusuke Yamaoka1, Akio Shiomi1, Hiroyasu Kagawa1, Hitoshi Hino1, Shoichi Manabe1, Shunichiro Kato1, Marie Hanaoka1, Akifumi Notsu2.   

Abstract

Aim: To clarify the impact of metastatic lymph node size on long-term outcomes in patients undergoing curative colectomy for pathological stage III colon cancer. Patients and
Methods: This study enrolled patients who underwent curative colectomy for pStage III colon cancer between January 2013 and December 2015. All patients were divided into four groups based on the short-axis diameter of the largest MLN: Group A, <5 mm; Group B, ≥5 mm and <10 mm; Group C, ≥10 mm and <15 mm; Group D, ≥15 mm.
Results: A total of 209 patients were analyzed. The 5-year recurrence-free survival rates of Groups A, B, C, and D were 82.3%, 74.6%, 74.5% and 60.7%, respectively. In multivariate analysis, Group D (hazard ratio=3.95; 95% confidence interval, 1.34-11.65; p=0.01) was independently associated with worse RFS.
Conclusion: Bulky MLNs might be a poor prognostic factor in node-positive colon cancer. Copyright 2022, International Institute of Anticancer Research.

Entities:  

Keywords:  Colon cancer; long-term outcome; lymph node metastasis; lymph node size; stage III colon cancer

Year:  2022        PMID: 35400003      PMCID: PMC8962840          DOI: 10.21873/cdp.10073

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  25 in total

1.  The prognostic significance of lymph node size in patients with squamous esophageal cancer.

Authors:  Dipok Kumar Dhar; Mitsuo Tachibana; Naoko Kinukawa; Maruyama Riruke; Hitoshi Kohno; Alex G Little; Naofumi Nagasue
Journal:  Ann Surg Oncol       Date:  2002-12       Impact factor: 5.344

2.  The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.

Authors:  Richard S Swanson; Carolyn C Compton; Andrew K Stewart; Kirby I Bland
Journal:  Ann Surg Oncol       Date:  2003 Jan-Feb       Impact factor: 5.344

3.  The distribution of lymph node metastases and their size in colon cancer.

Authors:  Yusuke Yamaoka; Yusuke Kinugasa; Akio Shiomi; Tomohiro Yamaguchi; Hiroyasu Kagawa; Yushi Yamakawa; Akinobu Furutani; Shoichi Manabe
Journal:  Langenbecks Arch Surg       Date:  2017-10-05       Impact factor: 3.445

4.  Prognostic significance of the number of lymph nodes examined in colon cancer surgery: clinical application beyond simple measurement.

Authors:  Yojiro Hashiguchi; Kazuo Hase; Hideki Ueno; Hidetaka Mochizuki; Yoshiki Kajiwara; Takashi Ichikura; Junji Yamamoto
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

5.  Lymph node hypoplasia is associated with adverse outcomes in node-negative colon cancer using advanced lymph node dissection methods.

Authors:  Patrick Mayr; Georg Aumann; Tina Schaller; Gerhard Schenkirsch; Matthias Anthuber; Bruno Märkl
Journal:  Langenbecks Arch Surg       Date:  2016-02-16       Impact factor: 3.445

6.  Clinical significance of colorectal cancer: metastases in lymph nodes < 5 mm in size.

Authors:  M A Rodriguez-Bigas; S Maamoun; T K Weber; R B Penetrante; L E Blumenson; N J Petrelli
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

7.  Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer.

Authors:  Yusuke Yamaoka; Yusuke Kinugasa; Akio Shiomi; Tomohiro Yamaguchi; Hiroyasu Kagawa; Yushi Yamakawa; Masakatsu Numata; Akinobu Furutani
Journal:  Int J Colorectal Dis       Date:  2017-07-31       Impact factor: 2.571

8.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Authors:  Yojiro Hashiguchi; Kei Muro; Yutaka Saito; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Kiyoshi Hasegawa; Kinichi Hotta; Hideyuki Ishida; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Yusuke Kinugasa; Keiko Murofushi; Takako Eguchi Nakajima; Shiro Oka; Toshiaki Tanaka; Hiroya Taniguchi; Akihito Tsuji; Keisuke Uehara; Hideki Ueno; Takeharu Yamanaka; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Michio Itabashi; Kentaro Sakamaki; Keiji Sano; Yasuhiro Shimada; Shinji Tanaka; Hiroyuki Uetake; Shigeki Yamaguchi; Naohiko Yamaguchi; Hirotoshi Kobayashi; Keiji Matsuda; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2019-06-15       Impact factor: 3.402

9.  Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance).

Authors:  R Cohen; Q Shi; J Meyers; Z Jin; M Svrcek; C Fuchs; F Couture; P Kuebler; K K Ciombor; J Bendell; A De Jesus-Acosta; P Kumar; D Lewis; B Tan; M M Bertagnolli; P Philip; C Blanke; E M O'Reilly; A Shields; J A Meyerhardt
Journal:  Ann Oncol       Date:  2021-07-20       Impact factor: 51.769

10.  The size of retrieved lymph nodes correlates with the number of retrieved lymph nodes and is an independent prognostic factor in patients with stage II colon cancer.

Authors:  Kazutake Okada; Sotaro Sadahiro; Toshiyuki Suzuki; Akira Tanaka; Gota Saito; Shinobu Masuda; Yasuo Haruki
Journal:  Int J Colorectal Dis       Date:  2015-08-12       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.